Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Oncology (Williston Park, N.Y.)|April 17, 2017
Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal CancerMarwan Al-Hajeili, Anthony F Shields, Jimmy J Hwang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Imaging DNA synthesis in vivo with 18F-FMAU and PETHaihao Sun, Thomas J Mangner, Jerry M Collins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Phase I study of bryostatin 1 and gemcitabineBasil F El-Rayes, Shirish Gadgeel, Anthony F Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Cancer|February 24, 2025
The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance)Justin C Brown, Chao Ma, Qian Shi, et al.
The Oncologist|April 29, 2018
Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be EnoughBenjamin A Weinberg, Joanne Xiu, Jimmy J Hwang, et al.
Clinical Colorectal Cancer|December 8, 2014
PET scans as a predictive marker of survival in advanced colorectal cancerMinsig Choi, Sri Lakshmi S Kollepara, Lance K Heilbrun, et al.
American Journal of Clinical Oncology|October 7, 2009
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancerMinsig Choi, Lance K Heilbrun, Raghu Venkatramanamoorthy, et al.
American Journal of Clinical Oncology|April 7, 2007
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorinBasil F El-Rayes, Mark Zalupski, Anthony F Shields, et al.
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Oncology (Williston Park, N.Y.)|April 17, 2017
Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal CancerMarwan Al-Hajeili, Anthony F Shields, Jimmy J Hwang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Imaging DNA synthesis in vivo with 18F-FMAU and PETHaihao Sun, Thomas J Mangner, Jerry M Collins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Phase I study of bryostatin 1 and gemcitabineBasil F El-Rayes, Shirish Gadgeel, Anthony F Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Cancer|February 24, 2025
The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance)Justin C Brown, Chao Ma, Qian Shi, et al.
The Oncologist|April 29, 2018
Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be EnoughBenjamin A Weinberg, Joanne Xiu, Jimmy J Hwang, et al.
Clinical Colorectal Cancer|December 8, 2014
PET scans as a predictive marker of survival in advanced colorectal cancerMinsig Choi, Sri Lakshmi S Kollepara, Lance K Heilbrun, et al.
American Journal of Clinical Oncology|October 7, 2009
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancerMinsig Choi, Lance K Heilbrun, Raghu Venkatramanamoorthy, et al.
American Journal of Clinical Oncology|April 7, 2007
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorinBasil F El-Rayes, Mark Zalupski, Anthony F Shields, et al.
Pageof 19